EGA
CCXI

Eagle Global Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Eagle Global Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-62,640
Closed -$586K – 388
2017
Q2 		$586K Buy
62,640
+16,310
+35% +$120K 0.02% 199
2017
Q1 		$337K Buy
+46,330
New +$334K 0.01% 267
2015
Q4 		– Sell
-12,287
Closed -$74K – 397
2015
Q3 		$74K Sell
12,287
-27,595
-69% -$200K ﹤0.01% 356
2015
Q2 		$328K Buy
39,882
+15,942
+67% +$127K 0.01% 278
2015
Q1 		$181K Buy
+23,940
New +$187K ﹤0.01% 322

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eagle Global Advisors's CCXI Position: Q3 2017 in Review

Eagle Global Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2017, closing a stake of 62,640 shares — an estimated $586K sold.

Eagle Global Advisors first reported a position in CCXI in Q1 2015 and held it in 5 quarters. The position peaked at $586K in Q2 2017. 86 funds tracked by Wall St. Rank hold CCXI as of Q3 2017.

  • Eagle Global Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 62,640 ChemoCentryx, Inc. shares in Q3 2017, an estimated $586K.
  • Eagle Global Advisors first reported a position in ChemoCentryx, Inc. in Q1 2015 and held it in 5 quarters.
  • Eagle Global Advisors's ChemoCentryx, Inc. position peaked at $586K in Q2 2017.
  • 86 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.